Somatostatin, glucagon, and insulin secretion from isolated perfused pancreas of new genetically obese hyperglycemic rats. 1984

Y Seino, and S Seino, and M Usami, and K Tsuda, and J Takemura, and S Nishi, and H Ishida, and H Imura

Insulin, somatostatin, and glucagon release from the perfused pancreas was studied in the newly developed genetically obese hyperglycemic hyperinsulinemic (Wistar fatty) rat. Insulin and somatostatin levels rose significantly compared to those in lean littermate controls during arginine infusion. The glucagon increase, however, was significantly less when total amounts during arginine infusion were calculated. These results show that hypersecretion of insulin and somatostatin in vitro may suppress glucagon release in Wistar fatty rats.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D010179 Pancreas A nodular organ in the ABDOMEN that contains a mixture of ENDOCRINE GLANDS and EXOCRINE GLANDS. The small endocrine portion consists of the ISLETS OF LANGERHANS secreting a number of hormones into the blood stream. The large exocrine portion (EXOCRINE PANCREAS) is a compound acinar gland that secretes several digestive enzymes into the pancreatic ductal system that empties into the DUODENUM.
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D011922 Rats, Mutant Strains Rats bearing mutant genes which are phenotypically expressed in the animals. Mutant Strains Rat,Mutant Strains Rats,Rat, Mutant Strains,Strains Rat, Mutant,Strains Rats, Mutant
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D000078790 Insulin Secretion Production and release of insulin from PANCREATIC BETA CELLS that primarily occurs in response to elevated BLOOD GLUCOSE levels. Secretion, Insulin

Related Publications

Y Seino, and S Seino, and M Usami, and K Tsuda, and J Takemura, and S Nishi, and H Ishida, and H Imura
August 1984, The American journal of physiology,
Y Seino, and S Seino, and M Usami, and K Tsuda, and J Takemura, and S Nishi, and H Ishida, and H Imura
February 1980, The American journal of physiology,
Y Seino, and S Seino, and M Usami, and K Tsuda, and J Takemura, and S Nishi, and H Ishida, and H Imura
May 1983, Horumon to rinsho. Clinical endocrinology,
Y Seino, and S Seino, and M Usami, and K Tsuda, and J Takemura, and S Nishi, and H Ishida, and H Imura
November 1998, Biochemical and biophysical research communications,
Y Seino, and S Seino, and M Usami, and K Tsuda, and J Takemura, and S Nishi, and H Ishida, and H Imura
May 1979, Life sciences,
Y Seino, and S Seino, and M Usami, and K Tsuda, and J Takemura, and S Nishi, and H Ishida, and H Imura
December 1979, Metabolism: clinical and experimental,
Y Seino, and S Seino, and M Usami, and K Tsuda, and J Takemura, and S Nishi, and H Ishida, and H Imura
June 1978, Diabetologia,
Y Seino, and S Seino, and M Usami, and K Tsuda, and J Takemura, and S Nishi, and H Ishida, and H Imura
January 1976, Acta biologica et medica Germanica,
Y Seino, and S Seino, and M Usami, and K Tsuda, and J Takemura, and S Nishi, and H Ishida, and H Imura
February 1986, Biochemical and biophysical research communications,
Y Seino, and S Seino, and M Usami, and K Tsuda, and J Takemura, and S Nishi, and H Ishida, and H Imura
August 1995, Endocrine journal,
Copied contents to your clipboard!